[11C]GO-289

N/A

Report date: 2023/11/02 17:44:24
NME

Base Information

Drug Name[11C]GO-289
Drug Alias Name[11C]GO289[11C]GO-289
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCasein kinase II inhibitors
TargetsCasein kinase II
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Center For Geriatrics And Gerontology, JapanGifu University of Medical Science
China Registration ClassN/A

Develop Information

Active CompaniesNational Center For Geriatrics And Gerontology, JapanGifu University of Medical Science
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A